<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Inherited forms of dystonia*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Inherited forms of dystonia*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Inherited forms of dystonia*</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Â </td> <td class="subtitle1">Usual onset</td> <td class="subtitle1">Locus symbol</td> <td class="subtitle1">Gene locus</td> <td class="subtitle1">Gene symbol</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Autosomal dominant</td> </tr> <tr> <td class="subtitle3_left" colspan="5">Dystonia is the presenting or predominant manifestation</td> </tr> <tr> <td class="indent2">Early-onset generalized dystonia (DYT-TOR1A)</td> <td>Childhood to adolescence</td> <td>DYT1</td> <td>9q34</td> <td><em>TOR1A</em></td> </tr> <tr> <td class="indent2">Dopa-responsive dystonia; Segawa syndrome (DYT-GCH1)</td> <td>Childhood</td> <td>DYT5a</td> <td>14q22</td> <td><em>GCH1</em></td> </tr> <tr> <td class="indent2">Adolescent-onset dystonia of mixed type (DYT-THAP1)</td> <td>Adolescence</td> <td>DYT6</td> <td>8p11.21</td> <td><em>THAP1</em></td> </tr> <tr> <td class="indent2">Cranial-cervical dystonia (DYT-GNAL)</td> <td>Adulthood</td> <td>DYT25</td> <td>18p11.21</td> <td><em>GNAL</em></td> </tr> <tr> <td class="indent2">Early-onset generalized dystonia (DYT-KMT2B)</td> <td>Childhood</td> <td>DYT28</td> <td>19q13.12</td> <td><em>KMT2B</em></td> </tr> <tr> <td class="subtitle3_left" colspan="5">Dystonia is an associated or secondary feature</td> </tr> <tr> <td class="indent2">Paroxysmal nonkinesigenic dyskinesia 1 (DYT-MR1)</td> <td>Adolescence to adulthood</td> <td>DYT8</td> <td>2q35</td> <td><em>MR1</em></td> </tr> <tr> <td class="indent2">Episodic (paroxysmal) kinesigenic dyskinesia 1 (DYT-PRRT2)</td> <td>Childhood to adolescence</td> <td>DYT10</td> <td>16p11.2</td> <td><em>PRRT2</em></td> </tr> <tr> <td class="indent2">Myoclonus-dystonia (DYT-SGCE)</td> <td>Childhood to adolescence</td> <td>DYT11</td> <td>7q</td> <td><em>SGCE</em></td> </tr> <tr> <td class="indent2">Myoclonus-dystonia (DYT-KCTD17)</td> <td>Childhood to early adulthood</td> <td>DYT26</td> <td>22q.12.3</td> <td><em>KCTD17</em></td> </tr> <tr> <td class="indent2">Rapid-onset dystonia-parkinsonism (DYT-ATP1A3)</td> <td>Childhood to adulthood</td> <td>DYT12</td> <td>19q</td> <td><em>ATP1A3</em></td> </tr> <tr> <td class="indent2">Paroxysmal exercise-induced dyskinesia (DYT-SLC2A1)</td> <td>Childhood</td> <td>DYT18</td> <td>1p34.2</td> <td><em>SLC2A1</em></td> </tr> <tr> <td class="indent2">Dentatorubral-pallidoluysian atrophy</td> <td>Adulthood</td> <td>N/A</td> <td>12p13.31</td> <td><em>ATN1</em></td> </tr> <tr> <td class="indent2">Friedreich ataxia</td> <td>Adolescence to adulthood</td> <td>N/A</td> <td>9q21.11</td> <td><em>FXN</em></td> </tr> <tr> <td class="indent2">Huntington disease</td> <td>Adolescence to adulthood</td> <td>N/A</td> <td>4p16.3</td> <td><em>HTT</em></td> </tr> <tr> <td class="indent2">Idiopathic basal ganglia calcification 1</td> <td>Adulthood</td> <td>N/A</td> <td>8p11.21</td> <td><em>SLC20A2</em></td> </tr> <tr> <td class="indent2">Neuroferritinopathy</td> <td>Adulthood</td> <td>NBIA3</td> <td>19q13.33</td> <td><em>FTL</em></td> </tr> <tr> <td class="indent2">Spinocerebellar ataxia 3 (Machado-Joseph disease)</td> <td>Childhood to adulthood</td> <td>SCA3</td> <td>14q32.12</td> <td><em>ATXN3</em></td> </tr> <tr> <td class="indent2">Spinocerebellar ataxia 17</td> <td>Adulthood</td> <td>SCA17</td> <td>6q27</td> <td><em>TBP</em></td> </tr> <tr> <td class="subtitle2_left" colspan="5">Autosomal recessive</td> </tr> <tr> <td class="subtitle3_left" colspan="5">Dystonia is the presenting or predominant manifestation</td> </tr> <tr> <td class="indent2">Dopa-responsive dystonia; Segawa syndrome (DYT-TH)</td> <td>Infancy to childhood</td> <td>DYT5b</td> <td>11p15.5</td> <td><em>TH</em></td> </tr> <tr> <td class="indent2">Dopa-responsive dystonia (DYT-SPR)</td> <td>Infancy to childhood</td> <td>N/A</td> <td>2p14-p12</td> <td><em>SPR</em></td> </tr> <tr> <td class="subtitle3_left" colspan="5">Dystonia is an associated or secondary feature</td> </tr> <tr> <td class="indent2">Aromatic L-amino acid decarboxylase deficiency</td> <td>Infancy</td> <td>N/A</td> <td>7p12.1</td> <td><em>DDC</em> (<em>AADC</em>)</td> </tr> <tr> <td class="indent2">Ataxia-telangiectasia</td> <td>Childhood</td> <td>N/A</td> <td>11q22.3</td> <td><em>ATM</em></td> </tr> <tr> <td class="indent2">Chorea-acanthocytosis</td> <td>Adulthood</td> <td>N/A</td> <td>9q21</td> <td><em>VPS13A</em></td> </tr> <tr> <td class="indent2">Fucosidosis</td> <td>Infancy</td> <td>N/A</td> <td>1p36.11</td> <td><em>FUCA1</em></td> </tr> <tr> <td class="indent2">Glutaric acidemia</td> <td>Infancy</td> <td>N/A</td> <td>19p13.2</td> <td><em>GCDH</em></td> </tr> <tr> <td class="indent2">Huntington disease-like 3</td> <td>Childhood</td> <td>HDL3</td> <td>4p15.3</td> <td>?</td> </tr> <tr> <td class="indent2">Infantile neuroaxonal dystrophy</td> <td>Infancy</td> <td>NBIA2a</td> <td>22q13.1</td> <td><em>PLA2G6</em></td> </tr> <tr> <td class="indent2">Juvenile parkinsonism</td> <td>Adolescence to adulthood</td> <td>PARK2</td> <td>6q26</td> <td><em>PRKN</em></td> </tr> <tr> <td class="indent2">Kufor-Rakeb syndrome</td> <td>Childhood to adulthood</td> <td>PARK9</td> <td>1p36.13</td> <td><em>ATP13A2</em></td> </tr> <tr> <td class="indent2">Methylmalonic aciduria</td> <td>Infancy</td> <td>N/A</td> <td> <p>6p12.3</p> 2q23.2</td> <td> <p><em>MUT</em></p> <em>MMADHC</em></td> </tr> <tr> <td class="indent2">Niemann-Pick disease type C</td> <td>Infancy to adulthood</td> <td>N/A</td> <td> <p>18q11-q12</p> 14q24.3</td> <td> <p><em>NPC1</em></p> <em>NPC2</em> (<em>HE</em>)</td> </tr> <tr> <td class="indent2">Pantothenate kinase-associated neurodegeneration</td> <td>Childhood</td> <td>NBIA1</td> <td>20p13</td> <td><em>PANK2</em></td> </tr> <tr> <td class="indent2">Tay-Sachs disease</td> <td>Infancy to adulthood</td> <td>N/A</td> <td>15q23</td> <td><em>HEXA</em></td> </tr> <tr> <td class="indent2">Wilson disease</td> <td>Childhood to adulthood</td> <td>N/A</td> <td>13q14.3</td> <td><em>ATP7B</em></td> </tr> <tr> <td class="indent2">Woodhouse-Sakati syndrome</td> <td>Adolescence</td> <td>N/A</td> <td>2q31.1</td> <td><em>DCAF17</em></td> </tr> <tr> <td class="subtitle2_left" colspan="5">X-linked</td> </tr> <tr> <td class="subtitle3_left" colspan="5">Dystonia is an associated or secondary feature</td> </tr> <tr> <td class="indent2">X-linked dystonia-parkinsonism; Lubag (DYT-TAF1)</td> <td>Adulthood</td> <td>DYT3</td> <td>XR</td> <td><em>TAF1</em></td> </tr> <tr> <td class="indent2">Lesch-Nyhan syndrome</td> <td>Childhood</td> <td>N/A</td> <td>Xq26.2-q26.3</td> <td><em>HPRT</em></td> </tr> <tr> <td class="indent2">Mohr-Tranebjaerg dystonia-deafness syndrome</td> <td>Childhood to adulthood</td> <td>N/A</td> <td>Xq22.1</td> <td><em>TIMM8A</em> (<em>DDP</em>)</td> </tr> <tr> <td class="indent2">Pelizaeus-Merzbacher disease</td> <td>Infancy</td> <td>N/A</td> <td>Xq22.2</td> <td><em>PLP1</em></td> </tr> <tr> <td class="indent2">Rett syndrome</td> <td>Infancy</td> <td>N/A</td> <td>Xq28</td> <td><em>MECP2</em></td> </tr> <tr> <td class="subtitle2_left" colspan="5">Mitochondrial</td> </tr> <tr> <td class="subtitle3_left" colspan="5">Dystonia is an associated or secondary feature</td> </tr> <tr> <td class="indent2">Leber optic atrophy</td> <td>Childhood to adolescence</td> <td>N/A</td> <td>N/A</td> <td>Multiple mitochondrial-encoded genes</td> </tr> <tr> <td class="indent2">Leigh syndrome<sup>Â¶</sup></td> <td>Infancy</td> <td>N/A</td> <td>N/A</td> <td>Multiple nuclear and mitochondrial-encoded genes</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>N/A: not assigned.</p>
<p>* This list is not comprehensive. An updated list of genetically determined movement disorders is maintained by the International Parkinson and Movement Disorder Society (MDS) at www.mdsgene.org.</p>
    
    Â¶ Leigh syndrome inheritance may be autosomal recessive or mitochondrial.</div><div class="graphic_reference">Data from:
    <ol>
<li><a href="http://www.ncbi.nlm.nih.gov/omim" target="_blank">Online Mendelian Inheritance in Man (OMIM)</a>.</li>
<li>Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013; 28:863.</li>
<li>Waugh JL, Sharma N. Clinical neurogenetics: dystonia from phenotype to genotype. Neurol Clin 2013; 31:969.</li>
<li>Klein C. Genetics in dystonia. Parkinsonism Relat Disord 2014; 20 Suppl 1:S137.</li>
<li>Moghimi N, Jabbari B, Szekely AM. Primary dystonias and genetic disorders with dystonia as clinical feature of the disease. Eur J Paediatr Neurol 2014; 18:79.</li>
<li>Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. Neurology 2012; 78:1016.</li>
</ol></div><div id="graphicVersion">Graphic 70477 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
